Implementing standardized provider documentation in a tertiary epilepsy clinic
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 18, 2019
- Accepted in final form December 17, 2019
- First Published June 16, 2020.
Article Versions
- Previous version (June 16, 2020 - 13:12).
- You are viewing the most recent version of this article.
Author Disclosures
- Felipe J.S. Jones, MD,
- Jason R. Smith, BA,
- Neishay Ayub, MD,
- Susan T. Herman, MD,
- Jeffrey R. Buchhalter, PhD, MD,
- Brandy E. Fureman, PhD,
- Sydney S. Cash, MD, PhD,
- Daniel B. Hoch, MD, PhD and
- Lidia M.V.R. Moura, MD, MPH
- Felipe J.S. Jones, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jason R. Smith, BA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Neishay Ayub, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Susan T. Herman, MD,
NONE
NONE
(1) Neuropace, Inc., travel to Experts Meeting
(1) Current Treatment Options in Neurology, editorial advisory board member, 2012-2019 (2) Journal of Clinical Neurophysiology, editorial advisory board member, 2013-2019 (3) Clinical Neurophysiology Practice, associate editor, 2016-2019
NONE
Epileptogenesis lecture, Henry Stewart Talks, 2013-2019
NONE
NONE
NONE
NONE
(1) Harvard Medical Faculty Practice, epilepsy patient care, 35%, 2012-2019, no benefit (2) Barrow Neurological Institute, epilepsy patient care, 35%, 2019, no benefit
(1) UCB Pharma (2) Acorda Therapeutics (3) Sage Therapeutics (4) NeuroPace, Inc. (5) Philips
(1) NIH/NINDS, #NS047029, co-investigator, 2014-2017
NONE
(1) American Epilepsy Society (2) Epilepsy Therapy Development Project
NONE
NONE
NONE
NONE
NONE
NONE
- Jeffrey R. Buchhalter, PhD, MD,
Data Safety Monitoring Board- UCB, Biviracetam dosing study DSMB- NINDS, Established Status Epilepticus Therapy Trial UCB, Inc- Biviracetam, data safety monitoring board
NONE
AAN, Quality Committee Epilepsy Foundation, Epilepsy Learning Healthcare System Pediatric Epilepsy Learning Healthcare System
NONE
NONE
NONE
Banner Thunderbird Medical Center (commercial entity, 2 years)
More than two years ago: Lundbeck Inc., Eisai Ltd., and Upsher-Smith During last 2 years: Insys (commercial), UCB (Commercial), Motive Medical Intelligence, Epilepsy Study Consortium (commercial) Weill Cornell Medicine (non-profit) Children's Healthcare of Atlanta (non-profit) Epilepsy Foundation (non-profit)
NONE
NONE
Banner Thunderbird Medical Center- general pediatric neurology practice in which these considerations could be relevant. Neither I nor my employer would benefit in a material fashion if these considerations were followed.
NONE
PCORnet infrastructure award, Epilepsy Learning Healthcare System, co-principle investigator, 2018-2020. Pediatric Epilepsy Research Fund, Pediatric Epilepsy Learning Healthcare System, leadership, 2018-2020
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Brandy E. Fureman, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1) UCB Biopharma SPRL "Biomarkers, health outcomes, and healthcare utilization in people with resistant focal epilepsy"
NONE
NONE
1) National Association of Epilepsy Centers "Epilepsy Learning Healthcare System" 2) Epilepsy Foundation of America; full-time employee of the Foundation since March 2016. Previous employer was NINDS/NIH.
NONE
NONE
NONE
NONE
NONE
NONE
- Sydney S. Cash, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Funded as PI from NIH/NINDS R01-NS062092 Stock/Stock Options, Medical Equipment & Materials: Beacon Biosignals, 2019
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Daniel B. Hoch, MD, PhD and
NONE
NONE
Spouse has spoken at the National Consortium of MS centers and received an honorarium. Stock/Stock Options, Medical Equipment & Materials: Merck, 1990- present Regeneron, 1990-present Biogen Idec, 1990-present Medtronic, 2010-present Cigna 2015-present Johnson and Johnson 2015-present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Lidia M.V.R. Moura, MD, MPH
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I received research support from NIH (1K08AG053380-01A1, 3P01AG032952-09S1, 1R01AG062282-01). I report no conflict of interest.
NONE
I receive funding from Epilepsy Foundation (i.e., Data Coordinating Center for the Epilepsy Learning Healthcare System). I report no conflict of interest.
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (F.J.S.J., J.R.S., N.A., S.S.C., D.B.H., L.M.V.R.M.), Massachusetts General Hospital, Harvard Medical School; Department of Neurology (S.T.H.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Department of Pediatrics (J.R.B.), Cumming School of Medicine, University of Calgary, Alberta, Canada; and Research and New Therapies (B.E.F.), Epilepsy Foundation, Landover, MD.
- Correspondence
Dr. Jones felipe.jones{at}mgh.harvard.edu
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.